POISONS SCHEDULING. Monique Reyes Senior Pharmaceutical Officer Pharmaceutical Regulatory Unit NSW Ministry of Health

Size: px
Start display at page:

Download "POISONS SCHEDULING. Monique Reyes Senior Pharmaceutical Officer Pharmaceutical Regulatory Unit NSW Ministry of Health"

Transcription

1 POISONS SCHEDULING Monique Reyes Senior Pharmaceutical Officer Pharmaceutical Regulatory Unit NSW Ministry of Health

2 Topics Schedules of the Poisons Standard (Cth) Poisons and Therapeutic Goods Act 1966 (NSW) Drug Misuse and Trafficking Act 1985 (NSW) Licences & Authorities

3 Poisons Standard aka SUSMP (Standard for the Uniform Scheduling of Medicines and Poisons) Scheduling is a national classification system for controls on how medicines and chemicals are made available to the public, and other restrictions on their supply and use. Medicines and chemicals are classified into Schedules according to the level of regulatory control over the availability of the medicine or chemical, required to protect public health and safety.

4 Schedules Schedule 1 Schedule 2 Schedule 3 Schedule 4 Schedule 5 Schedule 6 Schedule 7 Schedule 8 Schedule 9 Schedule 10 Not currently in use Pharmacy Medicine Pharmacist Only Medicine Prescription Only Medicine OR Prescription Animal Remedy Caution Poison Dangerous Poison Controlled Drug Prohibited Substance Substances of such danger to health as to warrant prohibition of sale, supply and use

5 Restriction on access and availability Schedule 9 Schedule 10 Schedule 8 Schedule 4 Schedule 7 Schedule 3 Schedule 2 Schedule 6 Schedule 5 Prohibited Substance Substances of such danger to health as to warrant prohibition of sale, supply and use Controlled Drug Prescription Only Medicine OR Prescription Animal Remedy Dangerous Poison Pharmacist Only Medicine Pharmacy Medicine Poison Caution

6 Poisons Schedule 5: Caution Substances with a low potential for causing harm, the extent of which can be reduced through the use of appropriate packaging with simple warnings and safety directions on the label, such as "CAUTION - KEEP OUT OF REACH OF CHILDREN READ SAFETY DIRECTIONS BEFORE OPENING OR USING". Schedule 6: Poison Substances with a moderate potential for causing harm, the extent of which can be reduced through the use of distinctive packaging with strong warnings and safety directions on the label, such as "POISON - KEEP OUT OF REACH OF CHILDREN READ SAFETY DIRECTIONS BEFORE OPENING".

7 Poisons Schedule 7: Dangerous Poison Substances with a high potential for causing harm at low exposure and which require special precautions during manufacture, handling or use. These poisons should be available only to specialised or authorised users who have the skills necessary to handle them safely. Special regulations restricting their availability, possession, storage or use may apply. Schedule 10: Substances of such danger to health as to warrant prohibition of sale, supply and use - Substances which are prohibited for the purpose or purposes listed for each poison.

8 Medicines Schedule 2: Pharmacy Medicine Substances, the safe use of which may require advice from a pharmacist and which should be available from a pharmacy or, where a pharmacy service is not available, from a licensed person. Schedule 3: Pharmacist Only Medicine Substances, the safe use of which requires professional advice but which should be available to the public from a pharmacist without a prescription.

9 Medicines Schedule 4: Prescription Only Medicine, or Prescription Animal Remedy Substances, the use or supply of which should be by or on the order of persons permitted by State or Territory legislation to prescribe and should be available from a pharmacist on prescription. Schedule 8: Controlled Drug Substances which should be available for use but require restriction of manufacture, supply, distribution, possession and use to reduce abuse, misuse and physical or psychological dependence.

10 Medicines/Poisons Prohibited Substance Substances which may be abused or misused, the manufacture, possession, sale or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of Commonwealth and/or State or Territory Health Authorities.

11 Derivatives of listed substances Schedule entry includes any concentration of all salts and derivatives of the poison unless it specifically states otherwise Similar in nature structurally, pharmacologically, and toxicologically Readily converted either physically or chemically to a scheduled poison There is no authority, other than the Courts, to determine the schedule of a substance that is not explicitly scheduled.

12 Exemptions to Scheduling Appendix A: general exemptions e.g. food, human blood products, radioisotopes for therapeutic use, in-vitro diagnostic analytical preparations (< 0.001% of an S1-S8) Appendix B: considered not to require control by scheduling e.g. ALCOHOL, DEHYDRATED Reason: Use pattern restricts hazard Area of use: Human therapeutic use Appendix G: dilute preparations - concentration cut-offs for specified poisons, where the Standard does not apply. Additionally, S1 to S6<10mg/L not scheduled

13 Advisory Committee on Scheduling Advisory Committee on Medicines Scheduling (ACMS) was established to advise and make recommendations to the Secretary of the Department of Health (or delegate) on the level of access required for medicines and in some instances chemicals Advisory Committee on Chemical Scheduling (ACCS) is the chemical counterpart Scheduling Policy Framework

14 Poisons and Therapeutic Goods Act 1966 NSW legislation Adopts Schedules 1 to 9 of the Poisons Standard, and interpretation provisions Regulates Schedule 10 Adopts packaging and labelling requirements of Standard Gives effect to Appendices A, B, F & K

15 NSW Licences and Authorities Licence to Supply by Wholesale of S2, S3, S4 and S8 Licence to Manufacture of S8 Authority to possess (but not supply) S8 for the purpose of analysis, research or instruction Authority to possess, use, manufacture or supply S9 for medical or scientific research, analytical, teaching or training purposes or for industrial or commercial purposes Authority to use, manufacture or supply S10

16 Drug Misuse and Trafficking Act 1985 Schedule 1 consists of substances in Schedule 4, Schedule 8, Schedule 9 of the SUSMP, and plants Provides for offences for possession, manufacture and supply of Schedule 1 DMTA and Schedule 9 of Standard Provides for offences for manufacture, supply and advertising of new psychoactive substances Provides for authority to possess, manufacture and supply Schedule 1 DMTA for the purpose of scientific research, instruction, analysis or study Relationship with Poisons and Therapeutic Goods Act

17 THE END Questions?

Drugs and Poisons Legislation Amendment (New Psychoactive and Other Substances) Act 2013 No 70

Drugs and Poisons Legislation Amendment (New Psychoactive and Other Substances) Act 2013 No 70 New South Wales Drugs and Poisons Legislation Amendment (New Psychoactive and Other Substances) Act 2013 No 70 Contents Page 1 Name of Act 2 2 Commencement 2 Schedule 1 Amendment of Drug Misuse and Trafficking

More information

Act on Narcotic Drugs and Psychotropic Substances and Precursors thereof

Act on Narcotic Drugs and Psychotropic Substances and Precursors thereof Issuer: Riigikogu Type: act In force from: 13.05.2016 In force until: 22.11.2018 Translation published: 06.05.2016 Act on Narcotic Drugs and Psychotropic Substances and Precursors thereof Amended by the

More information

Schedule Description Examples

Schedule Description Examples WHS OP033 Scheduled Medicine, Poisons and Drugs Procedure Section 1 - Overview (1) The Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP) is an Australian legislative instrument produced

More information

FACT SHEET PREPARED BY THE MINISTRY OF JUSTICE ON THE DANGEROUS DRUGS (AMENDMENT) ACT 2015 OVERVIEW 1. This Fact Sheet sets out the main changes that have been made to the Dangerous Drugs Act (the DDA

More information

Unofficial translation /Ministry of Social Affairs and Health. No. 548/2008. Government Decree on Narcotics Control

Unofficial translation /Ministry of Social Affairs and Health. No. 548/2008. Government Decree on Narcotics Control Unofficial translation /Ministry of Social Affairs and Health No. 548/2008 Government Decree on Narcotics Control Issued in Helsinki on 28 August 2008 Section 1 Scope of application This Decree lays down

More information

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system Medicinal cannabis What is medicinal cannabis? Broadly speaking, medicinal cannabis is cannabis prescribed to relieve the symptoms of a medical condition, such as epilepsy. It is important to make the

More information

I am pleased to highlight for this Honourable House and the public. that today the Government will be laying amendments to the

I am pleased to highlight for this Honourable House and the public. that today the Government will be laying amendments to the MINISTERIAL STATEMENT TO THE HOUSE OF ASSEMBLY BY THE HONOURABLE KIM N. WILSON, JP, MP MINISTER OF HEALTH UPDATES AND MODERNIZATION OF DRUG SCHEDULES 24 November 2017 Mr Speaker and Honourable Members,

More information

New regulatory requirements DPCS Regulations 2017

New regulatory requirements DPCS Regulations 2017 New regulatory requirements DPCS Regulations 2017 Prescribers and pharmacists May 2017 Table of Contents Explanatory notes... 1 Clarifying the meaning of key terms... 1 Chart instructions and prescriptions...

More information

Joy Wingfield LL M, MPhil, BPharm, FRPharmS, Dip Ag Vet Pharm, FCPP Honorary Professor of Pharmacy Law and Ethics, University of Nottingham, UK

Joy Wingfield LL M, MPhil, BPharm, FRPharmS, Dip Ag Vet Pharm, FCPP Honorary Professor of Pharmacy Law and Ethics, University of Nottingham, UK Dale and Appelbe's Pharmacy and Medicines Law SOHi Edited by Gordon E Appelbe LL B, PhD, MSc, BSc(Pharm), BA, FRPharmS, Hon MPS(Aus), FCPP, FCPP (Hons) Independent Pharmaceutical and Legal Consultant,

More information

Interstate dispensing : A case for uniform, intuitive legislation

Interstate dispensing : A case for uniform, intuitive legislation Interstate dispensing : A case for uniform, intuitive legislation Author Bernaitis, Nijole, King, Michelle, Hope, Denise Published 2014 Journal Title Journal of Law and Medicine Copyright Statement 2014

More information

Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016

Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016 Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016 To whom it may concern, Thank you for the opportunity to submit on the Draft Public Health (Tobacco) Regulations 2016

More information

40 Use and Supply of Drugs or Medicines in Optometric Practice

40 Use and Supply of Drugs or Medicines in Optometric Practice 40 Use and Supply of Drugs or Medicines in Optometric Practice Guideline 40.01 The optometrist has a duty to take due care in the use of drugs in optometric practice and to only supply drugs when it is

More information

MEDICAL COUNCIL OF NSW

MEDICAL COUNCIL OF NSW Drug screening policy Medical Council policies outline legislative principles and can also reflect the values/philosophies of the Medical Council. They direct conduct and decision making and must be complied

More information

Food Fortification Regulations, 2016 (Gazetted on 24 October, 2016) ARRANGEMENT OF SECTIONS PART I PRELIMINARY

Food Fortification Regulations, 2016 (Gazetted on 24 October, 2016) ARRANGEMENT OF SECTIONS PART I PRELIMINARY Statutory Instrument 120 of 2016 Food Fortification Regulations, 2016 (Gazetted on 24 October, 2016) [Cap 15:05 Section 1 Title 2 Interpretation ARRANGEMENT OF SECTIONS PART I PRELIMINARY 3 Inspection

More information

Thailand s experience in developing the Reclassification guideline

Thailand s experience in developing the Reclassification guideline Ms.Charunee Krisanaphan Pharmacist, Senior Professional level Standards and Regulations Division, Bureau of Control Thai Food and October 22, 2014 Outlines Definition Existed guideline Process of developing

More information

Submission to the Misuse of Drugs Amendment Bill September Society and its Role and Functions. 29 September 2010

Submission to the Misuse of Drugs Amendment Bill September Society and its Role and Functions. 29 September 2010 PHARMACY HOUSE 124 DIXON STREET PO BOX 11 640 WELLINGTON NEW ZEALAND TELEPHONE 04 802 0030 FAX 04 382 9297 EMAIL p.society@psnz.org.nz WEBSITE www.psnz.org.nz 29 September 2010 Clerk of the Health Committee

More information

Amending Your Land Use Bylaw To Prepare For The Retail Sale Of Cannabis

Amending Your Land Use Bylaw To Prepare For The Retail Sale Of Cannabis 1 Amending Your Land Use Bylaw To Prepare For The Retail Sale Of Cannabis The Federal Government has proposed that by July 2018 non -medical cannabis will be legalized in Canada. Currently, cannabis possession

More information

January 19, Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9

January 19, Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9 January 19, 2018 Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9 By email: cannabis@canada.ca RE: Proposed Approach to the Regulation of Cannabis

More information

Misuse of Drugs (Medicinal Cannabis) Amendment Bill

Misuse of Drugs (Medicinal Cannabis) Amendment Bill Misuse of Drugs (Medicinal Cannabis) Amendment Bill Departmental Report Prepared by the Ministry of Health 11 June 2018 1 Contents Introduction... 3 Submissions... 3 Overview... 3 Section One - Key topics

More information

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis I m here today to provide 1 2 3 Context for the Government of Canada s plan to legalize, regulate

More information

Monash University Procedure. High Risk Scheduled Drugs and Poisons Procedure (S8/9/11)

Monash University Procedure. High Risk Scheduled Drugs and Poisons Procedure (S8/9/11) Monash University Procedure Procedure Title Parent Policy High Risk Scheduled Drugs and Poisons Procedure (S8/9/11) OHS Policy Date Effective 19 September 2017 Review Date September 2020 Procedure Owner

More information

LAW ON PREVENTION AND SUPPRESSION OF THE ABUSE OF NARCOTIC DRUGS

LAW ON PREVENTION AND SUPPRESSION OF THE ABUSE OF NARCOTIC DRUGS LAW ON PREVENTION AND SUPPRESSION OF THE ABUSE OF NARCOTIC DRUGS CHAPTER I. GENERAL PROVISIONS Article 1 (Purpose of this Law) This Law is enacted in the implementation of the Single Convention on Narcotic

More information

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-FIFTH REGULAR SESSION April 29 - May 1, 2014 Washington, D.C. OEA/Ser.L/XIV.2.55 CICAD/doc.2106/14

More information

The Home Office Proposals to schedule pregabalin and gabapentin under the Misuse of Drugs Regulations 2001 January 2018

The Home Office Proposals to schedule pregabalin and gabapentin under the Misuse of Drugs Regulations 2001 January 2018 The Home Office Proposals to schedule pregabalin and gabapentin under the Misuse of Drugs Regulations 2001 January 2018 Prepared by: Adam Osprey Policy & Development Pharmacist adam.osprey@cps.scot Who

More information

Medicines in Schedule 1 to the Medicine Regulations 1984 that reference the manufacturer s original pack

Medicines in Schedule 1 to the Medicine Regulations 1984 that reference the manufacturer s original pack Medicines in Schedule 1 to the Medicine Regulations 1984 that reference the manufacturer s original pack Information paper for the Medicines Classification Committee Medsafe January 2018 1. Purpose The

More information

Update on the Legalization and Regulation of Cannabis. January 8, 2018 Regular Meeting of Delta Council

Update on the Legalization and Regulation of Cannabis. January 8, 2018 Regular Meeting of Delta Council Update on the Legalization and Regulation of Cannabis January 8, 2018 Regular Meeting of Delta Council Regulatory Authority for Cannabis Federal authority: Cultivation & Manufacturing Licensing, inspection,

More information

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis. February 2018

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis. February 2018 An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis February 2018 I m here today to provide 1 2 3 Context for the Government of Canada s plan to legalize,

More information

PIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES

PIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 040-1 3 Appendices 1 January 2019 PIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES PIC/S January 2019 Reproduction

More information

Supplement No. 1 published with Extraordinary Gazette No. 65 dated 19 th August, 2016.

Supplement No. 1 published with Extraordinary Gazette No. 65 dated 19 th August, 2016. CAYMAN ISLANDS Supplement No. 1 published with Extraordinary Gazette No. 65 dated 19 th August, 2016. A BILL FOR A LAW TO AMEND THE MISUSE OF DRUGS LAW (2014 REVISION) TO INCLUDE CANNABIS EXTRACTS AND

More information

Review of Controlled Drugs and Substances Act

Review of Controlled Drugs and Substances Act Review of Controlled Drugs and Substances Act Canadian Medical Association: Submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations A

More information

Guidance for Pharmacists on Extemporaneous Dispensing

Guidance for Pharmacists on Extemporaneous Dispensing Guidance for Pharmacists on Extemporaneous Dispensing Pharmaceutical Society of Ireland Version 1 June 2015 Contents 1. Introduction 2 2. Legislative Basis and Implications 3 3. Guidance 4 3.1 Key Responsibilities

More information

European Legal Database on Drugs

European Legal Database on Drugs European Legal Database on Drugs / Reviewing legal aspects of substitution treatment at international level Prepared by the EMCDDA at the request of the Pompidou Group Secretariat EMCDDA ELDD Comparative

More information

Understanding the New Access to Cannabis for Medical Purposes Regulations

Understanding the New Access to Cannabis for Medical Purposes Regulations Understanding the New Access to Cannabis for Medical Purposes Regulations Health Canada August 2016 Table of Contents 1. Introduction 2. Health Canada's role 3. What it means for health care practitioners

More information

Guidance for Pharmacists on the Safe Supply of Non-Prescription Levonorgestrel 1500mcg for Emergency Hormonal Contraception

Guidance for Pharmacists on the Safe Supply of Non-Prescription Levonorgestrel 1500mcg for Emergency Hormonal Contraception Guidance for Pharmacists on the Safe Supply of Non-Prescription Levonorgestrel 1500mcg for Emergency Hormonal Contraception Pharmaceutical Society of Ireland Version 4 December 2016 Updates made following

More information

Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients

Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients Pharmaceutical Society of Ireland Version 3 October 2017 Updates made following the enactment

More information

AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)

AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014) AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION (Moscow, 23 December 2014) Member States of the Eurasian Economic Union, hereinafter referred

More information

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices Name of Dental Practice : Objectives To ensure implementation of the regulations and guidance on safe and secure handling of midazolam and other controlled drugs (CDs) Scope To cover all aspects of obtaining

More information

ALCOHOL & DRUG USE INCIDENT MANAGEMENT POLICY

ALCOHOL & DRUG USE INCIDENT MANAGEMENT POLICY ALCOHOL & DRUG USE INCIDENT MANAGEMENT POLICY 1. RATIONALE Drug use by students increases the risk of injury to the students themselves and to others, as well as impairing the ability of students to respond

More information

STATUTORY INSTRUMENTS. S.I. No. 488 of 2008 REGULATION OF RETAIL PHARMACY BUSINESSES REGULATIONS 2008

STATUTORY INSTRUMENTS. S.I. No. 488 of 2008 REGULATION OF RETAIL PHARMACY BUSINESSES REGULATIONS 2008 STATUTORY INSTRUMENTS S.I. No. 488 of 2008 REGULATION OF RETAIL PHARMACY BUSINESSES REGULATIONS 2008 (Prn. A8/1883) 2 [488] 1. Citation. S.I. No. 488 of 2008 REGULATION OF RETAIL PHARMACY BUSINESSES REGULATIONS

More information

Substance Misuse (Drugs, Alcohol and Tobacco) Policy

Substance Misuse (Drugs, Alcohol and Tobacco) Policy Substance Misuse (Drugs, Alcohol and Tobacco) Policy Culture John Paul College is a Christian, ecumenical, do-educational College. Our values are based on a Christian ethos and particularly emphasise the

More information

WAREHOUSING AND DISTRIBUTION OF CANNABIS PRODUCTS. RACI Pharmaceutical Science Group (NSW) Supply and Use of Medicinal Cannabis

WAREHOUSING AND DISTRIBUTION OF CANNABIS PRODUCTS. RACI Pharmaceutical Science Group (NSW) Supply and Use of Medicinal Cannabis WAREHOUSING AND DISTRIBUTION OF CANNABIS PRODUCTS RACI Pharmaceutical Science Group (NSW) Supply and Use of Medicinal Cannabis 28 March 2017 Bruce Battye Director Pharmaceutical Regulatory Unit, NSW Health

More information

WORK HEALTH & SAFETY NEWSLETTER November

WORK HEALTH & SAFETY NEWSLETTER November WORK HEALTH & SAFETY NEWSLETTER November 1 2012 How WH&S applies to Men s Sheds What s all this about? Ever since the beginning of industry Governments, Unions and employers have introduced many rules

More information

How to change the legal classification of a medicine in New Zealand

How to change the legal classification of a medicine in New Zealand How to change the legal classification of a medicine in New Zealand Guidance document Medsafe October 2017 Page 1 of 15 Contents Purpose and scope... 3 Definitions... 3 Background and legislative context...

More information

Safe Prescribing and Dispensing of Controlled Drugs. Joint Guidance Medical Council and Pharmaceutical Society of Ireland

Safe Prescribing and Dispensing of Controlled Drugs. Joint Guidance Medical Council and Pharmaceutical Society of Ireland Safe Prescribing and Dispensing of Controlled Drugs Joint Guidance Medical Council and Pharmaceutical Society of Ireland Purpose of this Guidance Purpose of this Guidance This resource aims to facilitate

More information

Date Marking. User Guide. Standard Date Marking of Food. December 2013

Date Marking. User Guide. Standard Date Marking of Food. December 2013 Date Marking User Guide to Standard 1.2.5 Date Marking of Food December 2013 Contents Contents... ii Background... 1 Food Standards in Australia and New Zealand... 1 Responsibility of food businesses...

More information

Coversheet: Medicinal cannabis: 100 day action

Coversheet: Medicinal cannabis: 100 day action Coversheet: Medicinal cannabis: 100 day action Advising agencies Decision sought Proposing Ministers Ministry of Health Introduction of Misuse of Drugs Amendment Bill Hon Dr David Clark, Minister of Health

More information

Name of the Substance

Name of the Substance Name of the Substance 0. Do you have any information on the use of this substance in your country either for medical, scientific, industrial or other professional purposes, for non-medical consumption

More information

Drug and Alcohol Policy

Drug and Alcohol Policy Drug and Alcohol Policy Purpose Skillset Pty Ltd ( Skillset ) is committed to providing a safe and healthy work environment, so far as is reasonably practicable in which all workers are treated fairly,

More information

Legalization of non-medical Cannabis OPSBA Update September 08, 2017

Legalization of non-medical Cannabis OPSBA Update September 08, 2017 Legalization of non-medical Cannabis OPSBA Update September 08, 2017 Purpose To provide an update on the Ministry of Education s (EDU s) work in relation to the expected legalization and regulation of

More information

DRUG FREE WORKPLACE POLICY

DRUG FREE WORKPLACE POLICY GENERAL STATEMENT DRUG FREE WORKPLACE POLICY Kitsap County Government is obligated and committed to provide our employees and the citizens of Kitsap County with an alcohol and drug free, healthy, safe,

More information

LAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY

LAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY LAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY President s Office No. 13/PO DECREE of the PRESIDENT of the LAO PEOPLE S DEMOCRATIC REPUBLIC On the Promulgation of the Law

More information

Sub. S.B. 119 As Passed by the Senate

Sub. S.B. 119 As Passed by the Senate AM3404 Sub. S.B. 119 As Passed by the Senate Topic: Opioid Data and Communication Expansion Act moved to amend as follows: In line 1 of the title, after "4723.52," insert "4729.01, 4729.44, 4729.75, 4729.79,

More information

Ontario s Narcotics Strategy

Ontario s Narcotics Strategy Ontario s Narcotics Strategy Ontario Public Drug Programs Ministry of Health and Long-Term Care January 31, 2012 Ontario Harm Reduction Distribution Program Conference 2012 1 Background The Need for Action

More information

Recalling Resolution (59) 23 of 16 November 1959, on the extension of the activities of the Council of Europe in the social and cultural fields;

Recalling Resolution (59) 23 of 16 November 1959, on the extension of the activities of the Council of Europe in the social and cultural fields; Resolution ResAP(2007)1 on the classification of medicines as regards their supply (superseding Resolution ResAP(2000)1 on the classification of medicines which are obtainable only on medical prescription)

More information

Alcohol, Tobacco and Other Drugs Minimum Standard. April 2015

Alcohol, Tobacco and Other Drugs Minimum Standard. April 2015 Alcohol, Tobacco and Other Drugs Minimum Standard April 2015 Contents 1 Executive Summary... 2 2 More Information... 2 3 Using this Standard... 2 4 Standard Provisions... 2 4.1 Legislative Requirements...

More information

Medicines and Cosmetics Regulation Unvalidated References:

Medicines and Cosmetics Regulation Unvalidated References: Medicines and Cosmetics Regulation 2002 Unvalidated References: This reprint of this Statutory Instrument incorporates all amendments, if any, made before 25 November 2006 and in force at 16 May 2002....

More information

Federation of Saint Kitts and Nevis

Federation of Saint Kitts and Nevis Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD Multilateral Evaluation Mechanism MEM Federation of Saint Kitts and Nevis 2009 EVALUATION OF PROGRESS IN DRUG CONTROL

More information

Workplace Drug and Alcohol Policy

Workplace Drug and Alcohol Policy Workplace Drug and Alcohol Policy January 2017 This Drug and Alcohol Policy is intended for and includes but is not limited to all Students, Contractors and all others either directly or indirectly engaged

More information

REPUBLIC OF KENYA MINISTRY OF MEDICAL SERVICES PHARMACY AND POISONS BOARD

REPUBLIC OF KENYA MINISTRY OF MEDICAL SERVICES PHARMACY AND POISONS BOARD REPUBLIC OF KENYA MINISTRY OF MEDICAL SERVICES PHARMACY AND POISONS BOARD Ensuring the provision of quality, safe and efficacious pharmaceutical products and services. FUNCTIONS OF THE BOARD BACKGROUND

More information

1.1 State the nature and purpose of a personal licence. 1.2 State the period of validity of a personal licence

1.1 State the nature and purpose of a personal licence. 1.2 State the period of validity of a personal licence New qualification for the BIIAB Level 2 Award for Personal Licence Holders 603/2468/5 New unit for Legal and Social Responsibilities of a Personal Licence Holder - A/616/5204 Registration start date 1

More information

PHARMACY AND POISONS BOARD OF HONG KONG

PHARMACY AND POISONS BOARD OF HONG KONG CODE OF PRACTICE FOR LISTED SELLER OF POISONS- Draft Version PHARMACY AND POISONS BOARD OF HONG KONG This code of practice for Listed Seller of Poisons (the Code) sets out the standards and obligations

More information

Appendix F Federation of State Medical Boards

Appendix F Federation of State Medical Boards Appendix F Federation of State Medical Boards Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office SECTION I: PREAMBLE The (name of board) recognizes that the prevalence of addiction

More information

Greens NSW Drug Regulation and Harm Minimisation Policy

Greens NSW Drug Regulation and Harm Minimisation Policy Greens NSW Drug Regulation and Harm Minimisation Policy Revised February 2015 Principles The NSW Greens believe: 1. Drug use has occurred throughout history and this is unlikely to change. Further, abuse

More information

REGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011.

REGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011. REGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011. CHAPTER I Scope and definitions. Article 1 Scope.

More information

Cannabis Legalization and Regulation in British Columbia Discussion Paper

Cannabis Legalization and Regulation in British Columbia Discussion Paper Cannabis Legalization and Regulation in British Columbia Discussion Paper Introduction In 2015, the federal government committed to legalizing non-medical cannabis in Canada. On June 30, 2016, it established

More information

The Role of the Responsible Pharmacist (RP)

The Role of the Responsible Pharmacist (RP) The Role of the Responsible Pharmacist (RP) Pharmaceutical industry perspective Vuyo Mokoena: Senior Manager: Monitoring, Compliance and Professional Conduct (MCPC) Overview Background Legislative provision

More information

Draft Guidance for Pharmacists on Extemporaneous Dispensing. Version 1

Draft Guidance for Pharmacists on Extemporaneous Dispensing. Version 1 1. Introduction Draft Guidance for Pharmacists on Extemporaneous Dispensing Version 1 The purpose of this guidance is to assist pharmacists in discharging their legal and professional obligations to patients

More information

Cannabis Legalization

Cannabis Legalization Cannabis Legalization Meeting with Education Stakeholders October 26, 2018 Agenda 1. Welcome and Introductions (EDU) 2. Overview of Federal and Provincial cannabis legislation (MAG) 3. Overview of Licence

More information

TOBACCO SMOKING (CONTROL) ACT

TOBACCO SMOKING (CONTROL) ACT TOBACCO SMOKING (CONTROL) ACT ARRANGEMENT OF SECTIONS 1. Control of tobacco smoking. 2. Restriction on tobacco smoking advertisement. 3. Tobacco packages to contain certain information. 4. Penalties for

More information

Unit title: Legal and Social Responsibilities of a Personal Licence Holder

Unit title: Legal and Social Responsibilities of a Personal Licence Holder Unit Specification for Regulated Qualifications General information Unit title: Legal and Social Responsibilities of a Personal Licence Holder Unit Level: 2 Credit: 1 Guided Learning Hours: 1 SQA Unit

More information

The work of a poison control centre: What does it take?

The work of a poison control centre: What does it take? TECHNICAL WHITE PAPER The work of a poison control centre: What does it take? Polyxeni Neou, MD, PhD Director of the Poison Information Centre in Athens. Poison control centres (PCCs) have been set up

More information

PATIENT GROUP DIRECTION PROCEDURE

PATIENT GROUP DIRECTION PROCEDURE PATIENT GROUP DIRECTION PROCEDURE Date approved 2 October 2015 Version 3 Approved by Yvette Oade, Chief Medical Officer Procedure Lead Clinical Governance Lead - Medicines Management Procedure Author Karen

More information

Guideline for the Rational Use of Controlled Drugs

Guideline for the Rational Use of Controlled Drugs Guideline for the Rational Use of Controlled Drugs Ministry of Health Male' Republic of Maldives April 2000 Table of Contents Page Introduction.. 2 1. Procurement and Supply of Controlled Drugs 3 1.1 Import

More information

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH 11 MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH Background The rules in this section are designed to ensure that advertisements that include health claims (please see Section 13 for health claims

More information

Workplace Drug and Alcohol Policy

Workplace Drug and Alcohol Policy 1. Aim Workplace Drug and Alcohol Policy 1.1 Indigenous Consumer Assistance Network Ltd ( ICAN ) is committed to providing a safe and healthy work environment in which all workers are treated fairly, with

More information

Schedules of Controlled Substances: Placement of Furanyl fentanyl, 4- Fluoroisobutyryl fentanyl, Acryl fentanyl, Tetrahydrofuranyl fentanyl, and

Schedules of Controlled Substances: Placement of Furanyl fentanyl, 4- Fluoroisobutyryl fentanyl, Acryl fentanyl, Tetrahydrofuranyl fentanyl, and This document is scheduled to be published in the Federal Register on 11/29/2018 and available online at https://federalregister.gov/d/2018-26045, and on govinfo.gov Billing Code 4410-09-P DEPARTMENT OF

More information

A combination of licensed medication and professional support is four times more likely to achieve a stop in smoking behaviour.

A combination of licensed medication and professional support is four times more likely to achieve a stop in smoking behaviour. PHA Position Statement E-cigarettes 30 May 2014 The Public Health Agency (PHA) considers E-cigarettes with caution at this time. E-cigarettes are not licensed nicotine replacement products. They are not

More information

MICHIGAN MEDICAL MARIJUANA REGULATION: From Home Remedy to Criminalization. to State Regulated Industry. March 22, Stephen K.

MICHIGAN MEDICAL MARIJUANA REGULATION: From Home Remedy to Criminalization. to State Regulated Industry. March 22, Stephen K. MICHIGAN MEDICAL MARIJUANA REGULATION: From Home Remedy to Criminalization to State Regulated Industry Presentation to the Michigan Municipal League Capital Conference March 22, 2017 Stephen K. Postema

More information

California. Prescribing and Dispensing Profile. Research current through November 2015.

California. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile California Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

HACKNEY NEW SCHOOL DRUGS POLICY

HACKNEY NEW SCHOOL DRUGS POLICY HACKNEY NEW SCHOOL DRUGS POLICY Person(s) responsible Approval requirements Review frequency Headteacher Governors informed of changes Annual Date approved January 2019 Next review due August 2019 1. INTRODUCTION

More information

Issue: March 2016 PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES

Issue: March 2016 PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES Issue: March 2016 PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES CONTENTS

More information

Chapter 22. Uses and Limitations of Product Labeling for Public Safety

Chapter 22. Uses and Limitations of Product Labeling for Public Safety Chapter 22 Uses and Limitations of Product Labeling for Public Safety Purpose of Product Labeling Labeling is the main method of communication between a manufacturer and the user of the product. The information

More information

Criminal Justice (Psychoactive Substances) Bill Regulatory Impact Analysis

Criminal Justice (Psychoactive Substances) Bill Regulatory Impact Analysis Criminal Justice (Psychoactive Substances) Bill 2010 Regulatory Impact Analysis 1. Summary RIA Summary of Regulatory Impact Analysis (RIA) Department/Office: Department of Justice and Law Reform Stage:

More information

Re: Handling of gabapentin and pregabalin as Schedule 3 Controlled Drugs in health and justice commissioned services

Re: Handling of gabapentin and pregabalin as Schedule 3 Controlled Drugs in health and justice commissioned services To: Health and justice commissioners and providers Public Health England health and justice leads Her Majesty s Prison and Probation Service Home Office immigration removal centre leads Health and justice

More information

GUILSBOROUGH ACADEMY DRUGS EDUCATION POLICY

GUILSBOROUGH ACADEMY DRUGS EDUCATION POLICY GUILSBOROUGH ACADEMY DRUGS EDUCATION POLICY Policy Name Owner Statutory Vice Principal (Pastoral) No Date Ratified Review Due July 2018 July 2019 POLICY Guilsborough Academy recognises the effect of the

More information

Medicines in Schedule 1 to the Medicines Regulations 1984 that reference the manufacturer s original pack

Medicines in Schedule 1 to the Medicines Regulations 1984 that reference the manufacturer s original pack Medicines in Schedule 1 to the Medicines Regulations 1984 that reference the manufacturer s original pack Appendix 1 1. Name of Alclometasone Restricted; for dermal use in s containing 0.05% or less and

More information

Ringwood School Drug, Alcohol and Substance Misuse Policy

Ringwood School Drug, Alcohol and Substance Misuse Policy Ringwood School Drug, Alcohol and Substance Misuse Policy POLICY DETAILS Policy Name Policy Category Policy Number & Version Drug, alcohol and substance misuse policy Guidance and Achievement January 2017

More information

Patient Group Directions Policy

Patient Group Directions Policy Patient Group Directions Policy Category: Summary: Equality Analysis undertaken: Valid From: Date of Next Review: Approval Date/ Via: Distribution: Related Documents: Author(s): Further Information: This

More information

Health, Safety and Environment Management System. HSE-PRO-004 Drugs and Poisons Procedure

Health, Safety and Environment Management System. HSE-PRO-004 Drugs and Poisons Procedure Health, Safety and Environment Management System HSE-PRO-004 Drugs and Poisons Procedure 1 Table of Contents 1 Intent... 3 2 Scope... 3 3 Definitions... 4 4 Duty, Obligations and Responsibilities... 5

More information

Appearance before House of Commons Standing Committee on Health as part of its Study on the Government s Role in Addressing Prescription Drug Abuse

Appearance before House of Commons Standing Committee on Health as part of its Study on the Government s Role in Addressing Prescription Drug Abuse Opening Statement Appearance before House of Commons Standing Committee on Health as part of its Study on the Government s Role in Addressing Prescription Drug Abuse Dr. Chris Simpson, President-elect

More information

2. The inclusion of public health focused restrictions around the sale and supply of these products.

2. The inclusion of public health focused restrictions around the sale and supply of these products. 1 May 2013 Committee Secretariat Health Select Committee Parliament Buildings Wellington Submission on the Psychoactive Substances Bill (RPH) serves the Greater Wellington region, through its three District

More information

Medical Devices. SOUTH AFRICA Bowman Gilfillan

Medical Devices. SOUTH AFRICA Bowman Gilfillan Medical Devices SOUTH AFRICA Bowman Gilfillan CONTACT INFORMATION Llewellyn Parker Bowman Gilfillan PO Box 785812, Sandton, 2146 South Africa +27 11 669 9635 l.parker@bowman.co.za www.bowman.co.za 1. Definition

More information

Draft Guidelines on the Sale and Supply of Non- Prescription Medicinal Products from a Retail Pharmacy Business

Draft Guidelines on the Sale and Supply of Non- Prescription Medicinal Products from a Retail Pharmacy Business Draft Guidelines on the Sale and Supply of Non- Prescription Medicinal Products from a Retail Pharmacy Business To facilitate compliance with Regulations 5(1)(d), 5(1)(h) and 10 of the Regulation of Retail

More information

Questions & answers on the use of cannabis sativa L. and cannabinoids (such as cannabidiol) as foodstuffs or within foodstuffs

Questions & answers on the use of cannabis sativa L. and cannabinoids (such as cannabidiol) as foodstuffs or within foodstuffs Questions & answers on the use of cannabis sativa L. and cannabinoids (such as cannabidiol) as foodstuffs or within foodstuffs Table of contents 1. Is there a difference between Cannabis and hemp?... 2

More information

Impact Summary: Therapeutic Products Bill Personal Import of Medicine by mail/courier

Impact Summary: Therapeutic Products Bill Personal Import of Medicine by mail/courier Impact Summary: Therapeutic Products Bill Personal Import of Medicine by mail/courier Section 1: General information Purpose The Ministry of Health is solely responsible for the analysis and advice set

More information

Prescribing drugs of dependence

Prescribing drugs of dependence Prescribing drugs of dependence Prescribing drugs of dependence Avant supports: à Education and guidelines for practitioners about the legal obligations in prescribing drugs of dependence à Development

More information

Office of University Counsel and Secretary of the Board of Regents

Office of University Counsel and Secretary of the Board of Regents To: From: University of Colorado Research Faculty President Bruce D. Benson University Counsel Patrick T. O Rourke Date: March 11, 2014 Re: Legality of Marijuana Research Colorado is one of twenty states

More information

NC General Statutes - Chapter 90 Article 5E 1

NC General Statutes - Chapter 90 Article 5E 1 Article 5E. North Carolina Controlled Substances Reporting System Act. 90-113.70. Short title. This Article shall be known and may be cited as the "North Carolina Controlled Substances Reporting System

More information

Date Marking User Guide Standard Date Marking of Packaged Food September 2010

Date Marking User Guide Standard Date Marking of Packaged Food September 2010 Date Marking User Guide to Standard 1.2.5 Date Marking of Packaged Food September 2010 Background Food Standards in Australia and New Zealand The Australia New Zealand food standards system is a cooperative

More information